Tuberculosis (TB) is one of the deadliest infections responsible for millions of deaths yearly over the world from ancient time to till date. India is one of the high tuberculosis (TB) burden nations in the world accounting for nearly 20% of the worldwide rate constituting 9.4 million TB cases. India secures second position in harboring multi drug resistant (MDR) TB cases, i.e., around 99,000 cases. Standard sputum based strategies to detect pulmonary tuberculosis include sputum microscopy and culture. However, these traditional methods results in a delay in the detection of TB and in consequent beginning of treatment. To overcome such delays, in 2010, WHO endorsed a new molecular techniques CBNAAT (Xpert MTB/ RIF) which is a fully automated diagnostic test that simultaneously detects tuberculosis and rifampicin drug resistance associated with mutation of rpoB gene within few hours. In this review we present a general overview of TB including the pathogenesis, diagnosis as well as ability of CBNAAT to detect Pulmonary TB in humans.
A. History
In 1819, the French Theophile Laennac detects the presence of consolidation, pleurisy and pulmonary cavitation as pathogenic signs of pulmonary or extrapulmonary TB [7] . In 1843, the German doctor Philipp Friedrich Hermann Klencke succeeded tentatively within the generation of human and bovine shapes of TB by immunizing tubercle materials into liver and lungs of rabbits [8] . Some years later, in 1867, Theodor Albrecht Edwin Klebs tried to isolate the TB bacillus by sowing the tubercle material on egg white, stored in sterile flasks. In his tests, the culture was rapidly sloppy and it was simple to recognize portable bacilli, which causes the illness in guinea pigs after vaccination into the peritoneal depression [9] . Later on, the renowned scientist Robert Koch was isolates the tubercle bacillus using the methylene blue staining. He recognized, isolated and cultured the bacillus in animal serum. At long last, by vaccinating the bacillus into research facility animals, he reproduced the infection [10] . Robert Koch displayed this result to the Society of Physiology in Berlin on 24 March 1882, forming a breakthrough within the battle against TB disease [3] .
B. Transmission
Tuberculosis (TB) is transmitted to a vulnerable person from an infected individual by airborne particles, termedas droplet nuclei. These are 1-5 microns in diameter. These communicable droplet nuclei are minordroplets containing tubercle bacteria which are released when person having pulmonary tuberculosis cough, sneeze, laugh, shout etc. These droplet nuclei stay in the surrounding for few hours. Transmission takes place when an individual breathes in droplet nuclei containing tuberculosis bacteria. These droplet nuclei voyage into the upper respiratory tract via mouth and nasal openings. Thereafter, they move to the bronchi and at last to the alveoli and the lungs [11] .
C. Pathogenesis
TB is an airborne bacterial infection caused by M. Tuberculosis which infects other body organs and most commonly occurs in the lungs [12] . M. Tuberculosis is exposed to the air as droplet nuclei from sneezing, coughing or shouting of a person having pulmonary TB. Once the bacilli reach the alveoli, they are engulfed by alveolar macrophages resulting in the elimination of a greater number of breathe in tubercle bacilli [13] . The unaffected proportion increases in the macrophages and are released when the macrophages destruct. These tubercle bacilli move via the blood flow or lymphatic passages to different body tissues or organs, most commonly to the lungs [14] . There are five stages of pulmonary tuberculosis ([15]- [18] ) as mentioned below. 1) Stage I: This stage contains no significant growth of bacilli. The bacilli are usually eliminated by alveolar macrophages.
However, if the bacilli are not destroyed, they reproduce and alveolar macrophages are generally destroyed due to their multiplication. 2) Stage II: This is commonly known as symbiotic stage where the bacilli multiply logarithmically within non-activated macrophages of developing abrasion, called tubercle. These non-activated macrophages, further, enters the tubercle from main blood stream and are referred as monocytes [18] .
3) Stage III: In this, caseous necrosis occurs and the bacilli become stationary. The growth of M. tuberculosis is inhibited by immune reaction to tuberculin like antigens that are released from bacilli [16] . At this stage, the immune reaction is mainly tissue damaging, delayed type hypersensitivity, which destroys the bacilli laden macrophages of symbiotic stage. At the lesion, which contains a soildcaseouscentre,bacillidonotmultiplybecauseofbeingsurroundedbybothnonactivated macrophages (which permit intracellular multiplication of M. tb) as well as partly activated macrophages and immature epitheloid cells produced by cell mediated immunity. 
D. Tuberculosis Diagnosis
The identification of tuberculosis from clinical samples is mainly based on clinical characterization, demonstration of acid fast bacilli (AFB), histopathology and isolation of M. tuberculosis. Early diagnosis of tuberculosis has always remained a challenging problem especially in case of pauci-bacillary and extra-pulmonary forms. The foremost common strategy for TB diagnosis is smear microscopy which was developed around 100 years ago. Smear microscopy requires 10,000 to 1,00,000 organisms/ml and acid fast bacilli (AFB). It could be saprophytic or pathogenic mycobacteria [20] . The bacilli are examined in sputum smear under a microscope. It is classified as an acid-fast bacillus as Mycobacterium tuberculosis retains stains after being treated with acidic solution [21] . The Ziehl-Neelsen stain and the Kinyoun stain are the most commonly used acid-fast staining techniques. Auraminerhodamine staining [22] and fluorescence microscopy are also used. Smear microscopy plays an important role in early diagnosis of Mycobacterial infections as the method is highly specific, rapid and cheapest method used for detection of AFB in sputum. Recent advancement in smear microscopy is the arrival of fluorescence microscopy [23] . This alternate technique is known to have increased sensitivity (10% higher) when compared with ZiehlNeelsen (ZN) microscopy methods [24] . Fluorescent acid fast bacilli (AFB) can be visualized at lower magnification and smears can be observed in a lesser time (about 25% less) as compared to ZN smears. The sensitivity of microscopy is influenced by the quality of collected specimen, the quantity of mycobacterium present in the specimen, the processing method, the staining technique, and the quality of the observation [25] .
On the other hand, as of late presented, Xpert MTB/RIF test could be a novel, fast, mechanized, and cartridge-based NAA test that can identify TB beside rifampicin resistance straightforwardly from sputum inside 2 hours of collection [26] . The GeneXpert cartridges are pre-loaded with all of the essential reagents for test preparing, DNA extraction, enhancement, and laser discovery of the opened up rpo B quality target. A major advantage of the Xpert MTB/RIF test is that it can be precisely administrated with negligible hands-on specialized time. The affectability and specificity of this test has been detailed to be worthy for TB discovery [27] .
In the recent study of execution of Xpert MTB/RIF, among the 561 culture-positive patients (561/1730) III. EPIDEMIOLOGY OF TUBERCULOSIS Tuberculosis (TB) has been ranked as second leading cause of death among infectious diseases, globally, after HIV [26] . In 2013, approximately, 9 million people developed incident TB, whereas 1.5 million people died due to TB, including 0.4 million death among HIV positive individuals [26] . Though, most of the TB cases and deaths were among men, but the burden of tubercular infection was also observed higher in women and is increasing. In 2013, an approximate number of 3.3 million cases and 510,000 TB deaths occurred among women. Along with this, estimated number of 550,000 TB cases and 80,000 deaths were reported among children [26] . Since 1993, World Health Organization (WHO) declared TB as a global public health emergency. TB mortality rates have fallen by 45% since 1990 and incidence rates are also falling in developed countries. The estimated number of TB cases in 2013 in Asia and Africa were 56% and 29%, respectively. India has ranked first among six high burden countries with largest number of incident cases and has accounted for an estimated for 24% of all TB cases worldwide [26] . The annual risk of infection was observed to be 1.5%, while the TB mortality rate per 100,000 population was found to be 24 persons. About 4.2% (3.3-5.2) of HIV prevalence in incident cases was recorded [31] , [29] . The status of TB in tribal communities is found to be relatively serious as compared to non-tribal population. Various studies in Sahariya have reported variable overall prevalence of TB, e.g., the first report published by Chakma et al (1996) estimated the prevalence as 1270/100,000, which was followed by revised survey by Sharma et al [32] (as 29.75/100), Rao et al [33] (as 1518/100,000) and a recent revised estimate by Rao as 3294/100,000. Bhat et al [33] reported the prevalence for TB in various tribes of Madhya Pradesh to be 387/100,000 population. Variable rates of prevalence of pulmonary tuberculosis has been reported for other Indian tribes also, e.g., in Pahadis of Kashmir valley it is 260/100,000 population [34] , in tribes of Wardha district, Maharshtra the rate is 133/100,000 in Jawadhu tribe of North Arcot district, Tamil Nadu, it is 840/100,000 [35] , in tribes of Car Nicobar, 140/100,000 and in Baiga tribe of M. P. it is reported to be 146/100,000 of population. Diagnosis  of  tuberculosis  in  people  is  challenging  indeed  with progressive advances, the determination is frequently troublesome to affirm microbiologically in portion due to the paucibacillary nature of the malady. Clinical conclusion needs standardization, and conventional and atomic microbiologic strategies need affectability, especially in people. Most of the tests make strides affectability, but these tests cannot recognize tuberculosis infection from idle contamination and few need specificity. These apparatus have progress our capacity to identify Mycobacterium tuberculosis as well as MDR-TB.
IV. CONCLUSION

